News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Conference News TCT 2024 EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS L.A. McKeown October 28, 2024
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Conference News EACTS 2023 SWEDEHEART Hints at Mortality Benefit With Statins After SAVR Michael O'Riordan October 05, 2023
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Conference News TVT 2022 Surgical Explant or Redo for TAVI Failures? Some Registry Insights Michael O'Riordan June 10, 2022
News Conference News STS 2022 Modified Surgical MV Repair Stands Up to Replacement Michael O'Riordan February 03, 2022
News Conference News STS 2022 Higher Mortality After MV Surgery in Poorer Communities: STS Database Michael O'Riordan February 02, 2022
News Conference News EACTS 2021 More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients Michael O'Riordan October 18, 2021
News Conference News TCT 2020 Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2 Michael O'Riordan October 15, 2020
News Conference News TVT 2020 Device Explants After TAVR Rare but Risky Michael O'Riordan June 24, 2020
News Conference News ACC 2019 Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery Michael O'Riordan March 17, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
News Conference News The Structural Heart Disease Summit 2018 Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year Michael O'Riordan June 21, 2018
News Conference News ACC 2018 ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins Shelley Wood March 10, 2018
News Conference News CRT 2018 Ticagrelor: Better Platelet Blockade Post-TAVR? Michael O'Riordan March 07, 2018
News Conference News CRT 2018 Early Low-Risk TAVR Data Reassure, but Durability Questions Remain Michael O'Riordan March 05, 2018
News Conference News ESC 2017 European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts Shelley Wood August 27, 2017
News Conference News TVT 2017 Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base Michael O'Riordan June 17, 2017